Intel Corporation

Ariel Moshkovitz

Tamara Gaidar

Glen J Anderson

Omer Ben-Shalom

Jennifer Anne Healey

Giuseppe Beppe Raffa

Lenitra M Durham

Stephen R Brown

Kathy Yuen

Richard T Beckwith

Jamie Sherman

Joshua Ekandem

Yosi Govezensky

Oleg Pogorelik

Tomer Rider

Oren Arad

Steve J Brown

Ido Lapidot

Richard Beckwith

Technologies for managing a treatment program include a treatment management server, smart pills, and patient computing devices. The treatment management server is configured to generate treatment data usable by the smart pills to control a release of one or more drugs in patients. The treatment management server is also configured to transmit the treatment data to the smart pills, obtain physiological data associated with the patients, identify a preferred physiological response among the patients based on the physiological data, and identify the treatment data associated with the preferred physiological response. The smart pills are configured to obtain the treatment data, release one or more drugs into the patients based on the treatment data, sense physiological conditions in the patients, and transmit the physiological conditions to the treatment management server. The patient computing devices facilitate communication between the treatment management server and the smart pills. Other embodiments are described.

Technologies for managing a treatment program using smart pills

Various systems and methods for personal sensory drones are described herein. A personal sensory drone system includes a drone remote control system comprising: a task module to transmit a task to a drone swarm for the drone swarm to execute, the drone swarm including at least two drones; a transceiver to receive information from the drone swarm related to the task; and a user interface module to present a user interface based on the information received from the drone swarm.

Personal sensory drones

Technologies are described for delivering an active agent using an ingestible pill device, securing medication package content, and monitoring the medication package content. Examples of the technology include using an ingestible pill device to deliver an active agent, where release of the active agent can be based on patient authentication, analyzing sensor data to determine a condition for releasing the active agent, analyzing image data to identify a release point, etc. Examples of the technology also include using a monitoring device to secure a medication package using a cover and locking device, monitoring the medication package to detect access to the medication package, and tracking access to the medication package to determine medication adherence.

Methods and systems for securing, delivering, and monitoring use of an active agent

Growing community of inventors

Haifa, Israel

Ariel Moshkovitz